Patent · US Expired

4-[4-[4-[4-[[2-(2,4-difluoro phenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]ph enyl]triazolones

US4916134A · kind A · utility

23Cited by

6References

10Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Jan Heeres · Vosselaar, BE
Leo Jacobus Jozef Backx · Arendonk, BE
Louis Jozef Elisabeth Van Der Veken · Vosselaar, BE

Key dates

Filing date	Apr 7, 1989
Grant date	Apr 10, 1990
Priority date	—
Expiry date	Apr 7, 2009

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D233/56
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]m ethoxy]phenyl]-1-piperazinyl]phenyl]triazolones, their pharmaceutically acceptable acid addition salts and stereoisomeric forms having improved antimicrobial properties, compositions containing the same, and methods of inhibiting and/or eliminating the development of fungi and bacteria in warm-blooded animals suffering from diseases caused by these fungi and/or bacteria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.